Alterations in bone metabolism in children with inflammatory bowel disease: An in vitro study

Journal of Pediatric Gastroenterology and Nutrition

Volumn 24, Issue 3, 1997, Pages 289-295

  Hyams, Jeffrey S ^a,c   Wyzga, Nancy ^a,c   Kreutzer, Donald L ^a,b   Justinich, Christopher J ^a,c   Gronowicz, Gloria A ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^c Farmington   (United States)

Author keywords

Bone; Cytokines; Inflammation; Inflammatory bowel disease; Osteoblasts; Osteopenia

Indexed keywords

CALCIUM; INTERLEUKIN 6; SERUM ALBUMIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METABOLISM; CALVARIA; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA CONTENT; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FETUS; HUMAN; MALE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SCHOOL CHILD; SERUM; ULCERATIVE COLITIS;

ADOLESCENT; ANIMALS; BLOOD SEDIMENTATION; BONE AND BONES; BONE RESORPTION; CHILD; COLITIS, ULCERATIVE; COLLAGEN; COLLAGENASES; CROHN DISEASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-6; MALE; ORGAN CULTURE TECHNIQUES; PROLINE; RATS; SERUM ALBUMIN;

ANIMALIA;

EID: 0030941273     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199703000-00011     Document Type: Article

References (33)

1. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9.
2. Abitol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108:417-22.
3. Silvennoinen JA, Karttunen TJ, Niemala SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-6.
4. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-56.
5. Issenman RM, Atkinson SA, Radoja C, Fraher L. Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 1993;17:401-6.
6. Clements D, Motley RJ, Evans WD, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992;27:1055-60.
7. Ryde SJS, Clements D, Evans WD, et al. Total body calcium in patients with inflammatory bowel disease: a longitudinal study. Clin Sci 1991;80:319-24.
8. Vogelsang H, Ferenci P, Woloszczuk W, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989;34:1094-9.
9. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28: 410-5.
10. Hylander E, Ladefoged K, Madsen S. Calcium balance and bone mineral content following small intestinal resection. Scand J Gastroenterol 1981;16:167-76.
11. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P. Interleukin-1B stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 1991;10: 15-21.
12. Hughes FJ, Howells GL. Interleukin-6 inhibits bone formation in vitro. J Bone Miner Res 1993;21:21-8.
13. Wallach S, Avioli LV, Feinblatt JD, Carstens JH Jr. Cytokines and bone metabolism. Calcif Tissue Int 1993;53:293-6.
14. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1B by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989;30:835-8.
15. Pullman WE, Elsbury S, Kobayashi M, Hapen AJ, Doe WF. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 1992;102:529-37.
16. Braegger CP, Nicholls S, Murch SH, Stephens S, MacDonald TT. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992;339:89-91.
17. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL. Relationship of functional and antigenic interieukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 1993;104:1285-92.
18. Gronowicz G, Woodiel FN, McCarthy MB, Raisz LG. In vitro mineralization of fetal rat parietal bones in defined serum-free medium: effect of β-glycerol phosphate. J Bone Miner Res 1989;4:313-24.
19. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: final report on a therapeutic trial. Br Med J 1955;2:1041-8.
20. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
21. Peterkofsky B, Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971;10:988-94.
22. Peterkofsky B, Diegelmann R. Collagen biosynthesis during connective tissue development in chick embryo. Dev Biol 1972;28:443-53.
23. Kissane JM, Robins E. The fluorimetric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 1958;233:184-8.
24. Gronowicz GA, DeRome MA. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res 1994;2:193-201.
25. Gronowicz G, McCarthy MB, Raisz LG. Glucocorticoids stimulate bone resorption in cultured fetal rat parietal bones. J Bone Miner Res 1990;5:1223-30.
26. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257:88-91.
27. Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994;9:883-90.
28. Silvennoinen J, Risteli L, Karttunen T, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996;38:223-8.
29. Meunier PJ, Dempster DW, Edouard C, Chapuy MC, Arlot M, Charhon S. Bone histomorphometry in corticosteroid-induced osteoporosis in Cushing's syndrome. Adv Exp Med Biol 1984;171:191-200.
30. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ. Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone 1979;1:303-11.
31. Tatakis DN. Interleukin-1 and bone metabolism: a review. J Periodontol 1993;64:416-31.
32. Roodman GD. Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 1993;53(suppl):S94-8.
33. Gomes P, DuBoulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonie inflammatory bowel disease. Gut 1986;27:92-5.